Copyright
©The Author(s) 2022.
World J Nephrol. Jul 25, 2022; 11(4): 115-126
Published online Jul 25, 2022. doi: 10.5527/wjn.v11.i4.115
Published online Jul 25, 2022. doi: 10.5527/wjn.v11.i4.115
Figure 1 Membranous nephropathy.
Old classification of membranous nephropathy. PLA2R: Phospholipase A2 receptor; THSD7A: Thrombospondin type 1 domain containing 7A.
Figure 2 Structure of neural epidermal growth factor-1 protein.
TSPN: TSP-1-like domain; C-C: Coiled coil domain; VWC: Von Willebrand factor type C domain; EGF: EGF-like domains E.
Figure 3 Structure of Semaphorin.
Sema: Sema domain; PSI: Plexin-semaphorin-integrin; Ig: Immunoglobulin.
Figure 4 Distribution of podocyte antigens in patients with ‘primary’ membranous nephropathy.
PLA2R: Phospholipase A2 receptor; THSD7A: Thrombospondin type 1 domain containing 7A; NELL-1: Neural epidermal growth factor-like 1 protein; Sema: Sema domain.
Figure 5 Patient distribution according to antigen and presence of associated disease.
AD: Associated disease; NSAID: Nonsteroidal anti-inflammatory drug; EXT: Exostosin; MN: Membranous nephropathy; NCAM-1: Neural cell adhesion molecule 1; NELL-1: Neural epidermal growth factor like-1 protein; PCDH7: Protocadherin; PLA2R: Phospholipase A2 receptor; SEMA 3B: Semaphorin 3B; THSD7A: Thrombospondin type 1 domain containing 7A.
Figure 6 New proposed classification of membranous nephropathy.
PLA2R: Phospholipase A2 receptor; THSD7A: Thrombospondin type 1 domain containing 7A; NELL-1: Neural epidermal growth factor-like 1 protein; Sema: Sema domain; PCDH7: Protocadherin 7; EXT: Exostosin; NCAM-1: Neural cell adhesion molecule 1.
Figure 7 Schematic classification of different conditions leading to membranous nephropathy.
PLA2R: Phospholipase A2 receptor; THSD7A: Thrombospondin type 1 domain containing 7A; NELL-1: Neural epidermal growth factor-like 1 protein; Sema: Sema domain; PCDH7: Protocadherin 7; EXT: Exostosin; NCAM-1: Neural cell adhesion molecule 1; MN: Membranous nephropathy.
- Citation: Salvadori M, Tsalouchos A. New antigens involved in membranous nephropathy beyond phospholipase A2 receptor. World J Nephrol 2022; 11(4): 115-126
- URL: https://www.wjgnet.com/2220-6124/full/v11/i4/115.htm
- DOI: https://dx.doi.org/10.5527/wjn.v11.i4.115